4 ms·
for every single patient, sure, but if that's the cost of the treating the first patient (it being a revolutionary new procedure and all), and it goes down from
by fragmede 3y ago
for every single patient, sure, but if that's the cost of the treating the first patient (it being a revolutionary new procedure and all), and it goes down from there, then why shouldn't we?
- thfuran 3y agoPaying to develop and scale a significantly improved treatment for a condition that affects many people is an altogether different proposition. > then why shouldn't we? Ultimately, there's only so much economy to go around. What percentage of it are you willing to dedicate to treating that one condition? What about everything that can't be funded or produced as a result of that allocation?